These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8806626)

  • 21. Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage.
    Rucavado A; Soto M; Kamiguti AS; Theakston RD; Fox JW; Escalante T; Gutiérrez JM
    Thromb Haemost; 2001 Apr; 85(4):710-5. PubMed ID: 11341509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
    Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
    Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of bitiscetin, a von Willebrand factor-dependent platelet aggregation inducer.
    Hirotsu S; Mizuno H; Fukuda K; Qi MC; Matsui T; Hamako J; Morita T; Titani K
    Biochemistry; 2001 Nov; 40(45):13592-7. PubMed ID: 11695907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Domain structure of human von Willebrand factor, and its modulators involved in the platelet adhesion process in vitro].
    Fujimura Y; Fukui H; Usami Y; Titani K
    Rinsho Ketsueki; 1991 May; 32(5):475-80. PubMed ID: 1870263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation.
    Fukuda K; Doggett T; Laurenzi IJ; Liddington RC; Diacovo TG
    Nat Struct Mol Biol; 2005 Feb; 12(2):152-9. PubMed ID: 15665869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic effect of a protein-type I class snake venom metalloproteinase, kistomin, is mediated by affecting glycoprotein Ib-von Willebrand factor interaction.
    Hsu CC; Wu WB; Chang YH; Kuo HL; Huang TF
    Mol Pharmacol; 2007 Oct; 72(4):984-92. PubMed ID: 17609416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets.
    Nishio K; Fujimura Y; Niinomi K; Takahashi Y; Yoshioka A; Fukui H; Usami Y; Titani K; Ruggeri ZM; Zimmerman TS
    Am J Hematol; 1990 Apr; 33(4):261-6. PubMed ID: 2316510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib.
    Shin Y; Morita T
    Biochem Biophys Res Commun; 1998 Apr; 245(3):741-5. PubMed ID: 9588185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
    Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728.
    Fujimura Y; Holland LZ; Ruggeri ZM; Zimmerman TS
    Blood; 1987 Oct; 70(4):985-8. PubMed ID: 3498523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli.
    Sugimoto M; Ricca G; Hrinda ME; Schreiber AB; Searfoss GH; Bottini E; Ruggeri ZM
    Biochemistry; 1991 May; 30(21):5202-9. PubMed ID: 2036386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibronectin and 130-kDa molecule complex mimics snake venom botrocetin-like structure potentially modulating association between von Willebrand factor and vascular vessel wall.
    Katayama M; Nagata S; Hirai S; Miura S; Fujimura Y; Matusi T; Kato I; Titani K
    J Biochem; 1995 Feb; 117(2):331-8. PubMed ID: 7608121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.
    Kawasaki T; Taniuchi Y; Hisamichi N; Fujimura Y; Suzuki M; Titani K; Sakai Y; Kaku S; Satoh N; Takenaka T
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):947-53. PubMed ID: 8948455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib.
    Peng M; Lu W; Beviglia L; Niewiarowski S; Kirby EP
    Blood; 1993 May; 81(9):2321-8. PubMed ID: 8481512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model.
    Sanders WE; Read MS; Reddick RL; Garris JB; Brinkhous KM
    Lab Invest; 1988 Oct; 59(4):443-52. PubMed ID: 3262788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping von Willebrand factor A domain binding sites on a snake venom metalloproteinase cysteine-rich domain.
    Pinto AF; Terra RM; Guimaraes JA; Fox JW
    Arch Biochem Biophys; 2007 Jan; 457(1):41-6. PubMed ID: 17118332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of three alboaggregins purified from Trimeresurus albolabris venom.
    Peng M; Lu W; Kirby EP
    Thromb Haemost; 1992 Jun; 67(6):702-7. PubMed ID: 1509413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
    Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
    Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib.
    Sugimoto M; Mohri H; McClintock RA; Ruggeri ZM
    J Biol Chem; 1991 Sep; 266(27):18172-8. PubMed ID: 1917949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.